5 completed. 3 Phase 1, 2 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 3 | Completed 3 |
| Phase 2 | 2 | Completed 2 |
Follow 0.9% physiological saline: new trials by email Literature Review of 0.9% physiological saline trials Research Report on 0.9% physiological saline
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Single Ascending Doses of HER-096 in Healthy Subjects HER-096, Placebo - Parkinson Disease | Phase 1 | Completed | Herantis Pharma Plc. | 60 | 2023-03-29 | 2023-10-27 |
| Clinical Study With Lymfactin® in the Treatment of Patients With Secondary Lymphedema (AdeLE) Lymfactin® (1x10E11 vp), Placebo - Secondary Lymphedema | Phase 2 | Completed | Herantis Pharma Plc. | 39 | 2018-06-07 | 2025-07-09 |
| Tocilizumab for the Treatment of Familial Mediterranean Fever Tocilizumab Infusion RoAcemtra (EU), 0.9% physiological saline - Familial Mediterranean Fever | Phase 2 | Completed | University Hospital Tuebingen | 30 | 2018-04-23 | 2020-11-18 |
| Safety Study to Evaluate the Contact Sensitizing Potential of Topically Applied ZuraPrep™ and ZuraPrep™ Without IPA Chloraprep, 0.9% Physiological Saline, ZuraPrep without IPA - Surgical Site Infection | Phase 1 | Completed | Zurex Pharma, Inc. | 208 | 2014-07-01 | 2015-03-17 |
| Safety Study to Evaluate the Cumulative Irritation Potential of Topically Applied ZuraPrep™ and ZuraPrep™ Without IPA ChloraPrep, 0.1% Sodium Lauryl Sulfate, 0.9% Physiological Saline - Surgical Site Infection | Phase 1 | Completed | Zurex Pharma, Inc. | 40 | 2014-06-01 | 2014-10-27 |
Surgical Wound Infection (2) · Breast Neoplasms (1) · Familial Mediterranean Fever (1) · Lymphedema (1) · Parkinson Disease (1)
Herantis Pharma Plc. (2) · Zurex Pharma, Inc. (2) · University Hospital Tuebingen (1)
Finland (2) · United States (2) · Germany (1) · Sweden (1)
Aleksi Tornio, MD (1) · Anne Saarikko, MD, PhD (1) · Esther Campbell (1) · Maggie Butler, PhD (1) · Maria Mani, MD, PhD (1)
2017 (1)